Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
FDA Regulation Review Pathway

Oncology Center Of Excellence Comes Of Age at US FDA

  • News

Executive Summary

Our infographic details organizational structure and management of FDA’s first inter-center institute; five of 11 associate director positions are being filled on an acting basis.

Table

View full table

Advertisement

Related Content

Pink Sheet
US FDA Reorg: Defining The “Central” Purpose Of A Commissioner
Pink Sheet
Real-Time Oncology Review Quickly Grows Popular; Venclexta Is Latest To Join Pilot
Pink Sheet
US FDA's Cancer Review Staff Should All Move To Oncology Center of Excellence, Advocates Say
Pink Sheet
FDA's Oncology Center Of Excellence On Equal Terms With CDER In New Org Chart

Topics

Related Companies

Advertisement
Tags:
FDA Regulation Review Pathway
UsernamePublicRestriction

Register

PS125027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By